Legend Biotech to Participate in the Jefferies Global Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Citi Reiterates Buy Rating on Legend Biotech Corp. (LEGN)
May 31, 2024 5:30 AM EDTCiti analyst Wangbin Zhou reiterated a Buy rating and $95.00 price target on Legend Biotech Corp. (NASDAQ: LEGN)
The analyst comments "We had an update call with LEGN and they reiterated 2H24 sales growth, driven by on-track capacity ramp-up and 2-4L launch. Mgmt.... More
